Mind Medicine (MindMed) Inc.
MNMD
$6.59
$0.203.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 0.41% | -9.62% | -31.89% | 27.06% | 110.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.19% | 14.69% | -16.19% | 6.43% | 59.75% |
| Operating Income | -46.19% | -14.69% | 16.19% | -6.43% | -59.75% |
| Income Before Tax | -45.58% | 23.65% | 79.90% | -119.22% | -386.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.58% | 23.65% | 79.90% | -119.22% | -386.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.58% | 23.65% | 79.90% | -119.22% | -386.72% |
| EBIT | -46.19% | -14.69% | 16.19% | -6.43% | -59.75% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 30.21% | 61.08% | 89.22% | -74.41% | -356.58% |
| Normalized Basic EPS | 30.21% | 61.06% | 84.53% | -74.42% | -356.53% |
| EPS Diluted | 30.30% | 39.12% | 66.28% | -74.41% | -358.35% |
| Normalized Diluted EPS | 30.21% | 62.20% | 85.23% | -74.42% | -356.53% |
| Average Basic Shares Outstanding | 108.61% | 96.15% | 86.42% | 25.69% | 6.63% |
| Average Diluted Shares Outstanding | 108.61% | 102.01% | 95.21% | 25.69% | 6.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |